FUMAGALLI, CARLO
 Distribuzione geografica
Continente #
EU - Europa 2.886
AS - Asia 1.622
NA - Nord America 821
SA - Sud America 321
AF - Africa 32
OC - Oceania 1
Totale 5.683
Nazione #
RU - Federazione Russa 2.465
US - Stati Uniti d'America 777
SG - Singapore 459
CN - Cina 456
BR - Brasile 250
HK - Hong Kong 216
IT - Italia 195
VN - Vietnam 168
KR - Corea 113
DE - Germania 84
IN - India 74
BD - Bangladesh 40
AR - Argentina 34
JP - Giappone 31
FI - Finlandia 23
NL - Olanda 19
MX - Messico 18
EC - Ecuador 17
FR - Francia 17
GB - Regno Unito 16
CA - Canada 15
IQ - Iraq 14
AT - Austria 12
ZA - Sudafrica 11
IE - Irlanda 10
PL - Polonia 10
ID - Indonesia 9
UA - Ucraina 9
ES - Italia 7
CL - Cile 6
MA - Marocco 6
UZ - Uzbekistan 6
KE - Kenya 5
PY - Paraguay 4
SA - Arabia Saudita 4
VE - Venezuela 4
AL - Albania 3
BH - Bahrain 3
EG - Egitto 3
IL - Israele 3
MY - Malesia 3
PH - Filippine 3
PK - Pakistan 3
PT - Portogallo 3
TN - Tunisia 3
TR - Turchia 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
GT - Guatemala 2
JM - Giamaica 2
PE - Perù 2
SE - Svezia 2
SN - Senegal 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AM - Armenia 1
AU - Australia 1
BB - Barbados 1
BO - Bolivia 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
KH - Cambogia 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 5.683
Città #
Moscow 858
Santa Clara 219
Hong Kong 213
Singapore 180
Hefei 155
San Jose 155
Seoul 111
Ashburn 80
Ho Chi Minh City 66
Bengaluru 59
Hanoi 43
Munich 40
Naples 37
Beijing 35
Dallas 34
Los Angeles 27
The Dalles 23
São Paulo 20
Milan 19
Nuremberg 16
New York 14
Rio de Janeiro 13
Amsterdam 12
Helsinki 11
Dublin 10
Rome 10
Falkenstein 9
Vitulazio 9
Brooklyn 8
Mexico City 8
Turku 8
Baghdad 7
Caserta 7
Chennai 7
Haiphong 7
Warsaw 7
Belo Horizonte 6
Brasília 6
Council Bluffs 6
Curitiba 6
Da Nang 6
Florence 6
Quito 6
Tashkent 6
Vicenza 6
Boardman 5
Chicago 5
Formosa 5
Hải Dương 5
Johannesburg 5
Memphis 5
Nairobi 5
Orem 5
Ribeirão Preto 5
Toronto 5
Vienna 5
Angri 4
Atlanta 4
Buffalo 4
Guarulhos 4
Montreal 4
Phoenix 4
Poços de Caldas 4
Tokyo 4
Trentola-Ducenta 4
Verona 4
Asunción 3
Bari 3
Bắc Ninh 3
Campinas 3
Campo Grande 3
Changsha 3
Concepción 3
Fortaleza 3
Frankfurt am Main 3
Gravataí 3
Guangzhou 3
Guayaquil 3
Kingston 3
Lappeenranta 3
Manama 3
Quilmes 3
Riyadh 3
Saint-Domineuc 3
Santo André 3
Thái Bình 3
Tianjin 3
Torre del Greco 3
Alghero 2
Ambato 2
Arezzo 2
Baku 2
Bauru 2
Biên Hòa 2
Boca Raton 2
Brescia 2
Buenos Aires 2
Bến Tre 2
Cachoeiro de Itapemirim 2
Cairo 2
Totale 2.776
Nome #
Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value 141
Association of Obesity with Adverse Long-Term Outcomes in Hypertrophic Cardiomyopathy 137
Could Ghrelin Expression Regulate Diastolic Cardiac Function in Type 2 Diabetic Obese Patients? 133
Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study 125
GLP-1 receptor agonists-SGLT-2 inhibitors combination therapy and cardiovascular events after acute myocardial infarction: an observational study in patients with type 2 diabetes 123
Effects of combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists on CRT response and clinical outcomes in in type 2 diabetes mellitus patients receiving chronic anti-diabetic medications: A multicenter observational study 119
Comprehensive Geriatric Assessment to Optimize the Management of Older Patients With Transthyretin Cardiac Amyloidosis 111
Clinical Phenotype and Prognostic Significance of Frailty in Transthyretin Cardiac Amyloidosis 110
Clinical profile of trazodone users in a multisetting older population: data from the Italian GeroCovid Observational study 106
Clinical presentation and prognosis of COVID-19 in older adults with hypothyroidism: data from the GeroCovid observational study 106
Clinical risk score to predict in-hospital mortality in COVID-19 patients: a retrospective cohort study 105
Age-dependent diagnostic yield of echocardiography as a second-line diagnostic investigation in athletes with abnormalities at preparticipation screening 105
Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis 104
GLP-1 Receptor Agonists Are Associated with Reduced Ascending Aorta Dilatation in Patients with Type 2 Diabetes: A Prospective Study 102
Development of an Italian version of the Leicester cough questionnaire and its relationship with other symptom-specific measures for patients with chronic cough 101
Determinants of health status in older patients with transthyretin cardiac amyloidosis: a prospective cohort study 100
Anticoagulation in atrial fibrillation. A large real-world update 98
Clinical profile and outcome of cardiomyopathies in infants and children seen at a tertiary centre 98
Prognostic Value of Malnutrition, Frailty, and Physical Performance in Transthyretin Cardiac Amyloidosis: Insights From a Prospective Multicenter Cohort Study 96
Post-procedural fever after transcatheter aortic valve implantation: a retrospective single-centre study 94
Hypertrophic cardiomyopathy: prevalence of disease-specific red flags 92
From Atrial Fibrillation Management to Atrial Myopathy Assessment: The Evolving Concept of Left Atrium Disease in Hypertrophic Cardiomyopathy 91
Atrial fibrillation and COVID-19 in older patients: how disability contributes to shape the risk profile. An analysis of the GeroCovid registry 91
Frailty and caregiver relationship quality in older patients diagnosed with transthyretin cardiac amyloidosis 90
Impact of pregnancy on the natural history of women with hypertrophic cardiomyopathy 88
Real-World Use and Predictors of Response to Disopyramide in Patients with Obstructive Hypertrophic Cardiomyopathy 86
Candidacy and long-term outcomes of subcutaneous implantable cardioverter-defibrillators in current practice in patients with hypertrophic cardiomyopathy 84
Myocardial blood flow in patients with hypertrophic cardiomyopathy receiving perindopril (CARAPaCE): A pilot study 83
Lifetime Clinical Course of Hypertrophic Cardiomyopathy: Outcome of the Historical Florence Cohort Over 5 Decades 82
Low incidence of arrhythmic syncope and pacemaker implantation in older patients with bifascicular block and implantable cardiac monitor 82
Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosis 82
Prevalence and predictors of bradyarrhythmias requiring permanent pacing in patients with Anderson–Fabry disease 80
Somatically evoked cough responses help to identify patients with difficult-to-treat chronic cough: a six-month observational cohort study 78
International patient preferences for physician attire: results from cross-sectional studies in four countries across three continents 78
Heart failure with preserved ejection fraction in elderly. From pathophysiology to treatment: An unresolved problem 77
Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosis 76
Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy 75
Prognostic impact of right ventricular dysfunction in patients with severe aortic stenosis treated with trans-catheter aortic valve implantation 74
Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring 74
PCSK9 Inhibitors “Fast Track” Use Versus “Stepwise” Lipid-Lowering Therapy in Patients with Acute Coronary Syndrome: A Retrospective Single-Center Study in a “Real-World” Population 74
Validation of a multiple‑lead smartphone-based electrocardiograph with automated lead placement for layman use in patients with hypertrophic cardiomyopathy 74
Layman electrocardiographic screening using smartphone-based multiple‑lead ECG device in school children 73
β-blockers: Their new life from hypertension to cancer and migraine 73
Prognostic Value of a 6-Minute Walk Test in Patients With Transthyretin Cardiac Amyloidosis 73
Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy 72
Relationship between hyponatremia at hospital admission and cardiopulmonary profile at follow-up in patients with SARS-CoV-2 (COVID-19) infection 72
Strength of clinical indication and therapeutic impact of the implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy 72
Selection and Application of Tissue microRNAs for Nonendoscopic Diagnosis of Barrett's Esophagus 72
Optimal timing of follow-up cardiac magnetic resonance in patients with uncomplicated acute myocarditis 71
Predicting Mortality Risk in Older Hospitalized Persons With COVID-19: A Comparison of the COVID-19 Mortality Risk Score with Frailty and Disability 71
Change in prevalence of ATTR variants in Italy: results from a national survey 71
Progression and prognostic significance of electrocardiographic findings in patients with cardiac amyloidosis 68
Temporal Trend of Age at Diagnosis in Hypertrophic Cardiomyopathy: An Analysis of the International Sarcomeric Human Cardiomyopathy Registry 68
Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis 67
Is Metformin Use Associated with a More Favorable COVID-19 Course in People with Diabetes? 66
Long-Term Outcomes After Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: Insights From the SHARE Registry 64
Prevalence of Inherited Cardiac Diseases Among Young Patients Requiring Permanent Pacing 62
Targeted Medical Therapies for Hypertrophic Cardiomyopathy 61
Post-procedural fever after Transcatheter Aortic Valve Implantation (TAVI). A multi-centric study 59
Wild-type transthyretin cardiac amyloidosis: the need for a comprehensive geriatric assessment beyond age 58
MitraClip implantation in real-world: clinical relevance of different patterns of left ventricular remodeling 58
The American College of Cardology/American Heart Association Heart Failure Staging System Highlights Diagnostic Delay and Predicts Outcome in Transthyretin Cardiac Amyloidosis 57
Overweight and aging increase the risk of atrial fibrillation after cardiac surgery independently of left atrial size and left ventricular ejection fraction 56
Use of Smartphone-operated ECG for home ECG surveillance in COVID-19 patients 55
Long-Term Prevalence of Systolic Dysfunction in MYBPC3 Versus MYH7-Related Hypertrophic Cardiomyopathy 54
Development of a smartphone-based app to support the differential diagnosis in patients with primary left ventricular hypertrophy 51
Response to correspondence on 'Change in prevalence of ATTR variants in Italy' 47
Ranolazine in patients with chronic coronary syndromes: real-world data provide new evidence on the antiarrhythmic properties of the drug 41
Phenotypes of Vulnerability and Prognosis in Older Adults with Cardiovascular Disease 24
Impatto prognostico delle sindromi geriatriche nella gestione dell’amiloidosi cardiaca da transtiretina 22
Vericiguat for endothelial dysfunction and CRT response in non-responders: the VERCET prospective observational study 21
Environmental Pollutant-Induced Cardiopathogenesis Through Immune Dysfunction: The Emerging Role of Micro- and Nanoplastics 20
Effects of Vericiguat on the Mitochondrial Function and Clinical Outcomes in CRT Nonresponders Patients 15
Cascade genetic screening in families with hereditary transthyretin amyloidosis: diagnostic and prognostic impact 13
A Geriatric Assessment Score Predicting 1-Year Mortality and Functional Decline After TAVR: The GASS-TAVR Study 8
Totale 5.760
Categoria #
all - tutte 16.699
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.699


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20236 0 0 0 0 2 0 0 0 3 0 1 0
2023/2024137 0 0 4 1 2 0 1 29 9 15 33 43
2024/2025947 5 42 13 61 155 116 188 47 75 79 69 97
2025/20264.670 176 427 329 194 379 2.288 238 114 173 170 96 86
Totale 5.760